Capital expenditure · 2011–2025
Biocryst Pharmaceuticals capital expenditure
$2.5M+119.6% · FY2025
Biocryst Pharmaceuticals (BCRX) reported $2.5M in capital expenditure for fiscal 2025, +119.6% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $2.5M | +119.6% | Open → |
| FY20242024-12-31 | $1.1M | −48.2% | Open → |
| FY20232023-12-31 | $2.2M | +60.5% | Open → |
| FY20222022-12-31 | $1.4M | −43.4% | Open → |
| FY20212021-12-31 | $2.4M | +364.0% | Open → |
| FY20202020-12-31 | $514,000 | +49.9% | Open → |
| FY20192019-12-31 | $343,000 | −6.3% | Open → |
| FY20182018-12-31 | $366,000 | +11.6% | Open → |
| FY20172017-12-31 | $328,000 | −93.8% | Open → |
| FY20162016-12-31 | $5.3M | +3.0% | Open → |
| FY20152015-12-31 | $5.1M | +4,732.1% | Open → |
| FY20142014-12-31 | $106,000 | +253.3% | Open → |
| FY20132013-12-31 | $30,000 | −73.5% | Open → |
| FY20122012-12-31 | $113,000 | +105.5% | Open → |
| FY20112011-12-31 | $55,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +31.2%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biocryst Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/biocryst-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biocryst Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/biocryst-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-biocryst-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Biocryst Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biocryst-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-012240 · February 26, 2026
{{cite web |title=Biocryst Pharmaceuticals capital expenditure — 10-K (0001628280-26-012240) |url=https://www.sec.gov/Archives/edgar/data/882796/000162828026012240/bcrx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.